Gnosis Pay has moved into emergency containment after attackers exploited a vulnerability in the Delay Module used in its smart-contract wallet architecture, forcing an urgent withdrawal warning, a temporary reversal of guidance and a pledge to reimburse affected users in full. The breach, disclosed on 1 June, hit the payment product that connects self-custodial crypto wallets with card spending. The affected component is linked to the Zodiac […]
Scientists have identified a link between biological changes present at birth, the development of gut bacteria during infancy and early signs of autism spectrum disorder and attention-deficit/hyperactivity disorder by age three, raising fresh questions about how brain development may be shaped before and after delivery. A large birth-cohort study led by researchers at The Chinese University of Hong Kong’s Faculty of Medicine found that epigenetic marks in […]
Anthropic is expanding access to Claude Mythos Preview through Project Glasswing, widening a controlled cybersecurity programme at a time when North Korean-linked hackers are sharpening attacks against macOS users in the financial, venture capital, Web3 and cryptocurrency sectors. The San Francisco-based AI company plans to increase the number of Project Glasswing partners from about 50 to roughly 200 organisations across more than 15 countries, broadening access to […]
Moscow’s main security agency said it had uncovered a foreign intelligence operation that placed spyware on mobile phones used by senior officials, intensifying Russia’s long-running confrontation with Western governments over cyber espionage, communications security and control of digital infrastructure. Russia’s Federal Security Service said the operation involved the compromise of thousands of devices, including phones used by officials, diplomats and people linked to government agencies. The agency […]
French police detained 780 people after celebrations over Paris Saint-Germain’s Champions League triumph turned violent across Paris and several other cities, leaving officers injured, shops damaged and vehicles set on fire during a night of disorder that overshadowed the club’s second successive European title. The unrest broke out after PSG defeated Arsenal 4-3 on penalties following a 1-1 draw at the Puskás Aréna in Budapest on Saturday, […]
Arabian Post Staff -Dubai UAE regulators have approved the oral form of Wegovy for weight management and cardiovascular risk reduction, expanding access to one of the world’s most closely watched obesity treatments beyond weekly injections. Emirates Drug Establishment cleared Wegovy, the semaglutide medicine developed by Novo Nordisk, as a once-daily tablet for adults living with obesity or overweight linked to weight-related health conditions. The approval makes the […]
A destructive cyber campaign tied to Iran-linked operators has targeted organisations in the Middle East and abroad, deleting virtual machines, databases, partitions and backup repositories in attacks designed to cripple recovery as well as disrupt daily operations. The activity has been linked by forensic investigators to infrastructure and tactics associated with Black Shadow, a long-running threat group assessed by Israeli authorities and private researchers as operating on […]
Authorities in northern Italy have barred two July concerts by Kanye West and Travis Scott in Reggio Emilia, citing risks to public order and security after objections from civic and Jewish community groups over the planned appearances. The decision by Reggio Emilia prefect Salvatore Angieri halts two of the most prominent events planned for the Pulse of Gaia Festival at the RCF Arena, one of Europe’s largest […]
A malicious NuGet package posing as a Sicoob software development kit has exposed sensitive banking authentication data, intensifying concerns over attacks that exploit trust in open-source developer ecosystems. The package, published as Sicoob. Sdk, was presented as a C# SDK for integrations with Sicoob, one of Brazil’s largest cooperative financial systems. Versions 2.0.0 to 2.0.4 were found to collect client IDs, PFX passwords and base64-encoded PFX certificate […]
Russia-linked cyber operators tracked as GREYVIBE have used generative artificial intelligence tools including ChatGPT and Google Gemini to widen cyber-espionage operations against Ukraine-linked targets, signalling a shift in how lower-skilled threat groups can build lures, malware and infrastructure at speed. The activity, active since at least August 2025, has targeted military, government, civilian and business-related organisations through phishing emails, fake verification pages, fraudulent websites and custom malware. […]
Cybersecurity teams are racing to patch a Palo Alto Networks authentication-bypass flaw after confirmed exploitation against exposed GlobalProtect deployments raised the risk profile of a vulnerability first disclosed this month. Tracked as CVE-2026-0257, the flaw affects PAN-OS firewalls and Prisma Access environments where GlobalProtect portal or gateway services are configured with authentication override cookies and a vulnerable certificate setup. Successful exploitation allows an unauthenticated remote attacker to […]
Low levels of vitamin B12 and folate may be tied to persistent fatigue and weaker motivation even among adults who appear otherwise healthy, adding a nutritional dimension to a complaint often blamed on poor sleep, stress or heavy workloads. A research team in Japan examined blood markers and self-reported symptoms in about 600 healthy adults and found that higher levels of homocysteine, a compound that tends to […]
Solstice has moved to deepen utility for its SLX token by launching stSLX staking with a 20% base annual percentage yield funded from the protocol treasury, setting up an early test of whether incentive-led staking can stabilise a volatile token launch while widening participation in its Solana-based yield ecosystem. The staking product allows SLX holders to deposit tokens through the Solstice app and receive stSLX, a liquid […]
Spotify has expanded its mobile app with playlist folders, bulk editing, queue management, reshuffle controls and background downloads, marking one of its most practical upgrades for listeners who organise large music, podcast and audiobook libraries on phones. The update brings several desktop-style controls to iOS and Android, with playlist folders and in-playlist bulk actions being rolled out globally to all users. Premium subscribers gain additional tools, including […]
Linux Foundation has launched DNS-AID, an open source project designed to let AI agents discover, verify and connect with one another through the internet’s existing Domain Name System rather than through private registries, vendor directories or hardcoded configuration files. The project, initially developed at Infoblox, is being positioned as a neutral discovery layer for the emerging agentic web, where software agents are expected to act across websites, […]
Cannabidiol has shown signs of reducing damaging brain inflammation in Alzheimer’s disease experiments, strengthening scientific interest in immune-based approaches to a disorder still dominated by treatments aimed at amyloid plaques and tau tangles. A research team using an Alzheimer’s mouse model found that inhaled CBD, the non-intoxicating compound derived from cannabis, appeared to dampen immune pathways linked to neuroinflammation. The findings point to a possible mechanism through […]
Cryptocurrency developers have become the focus of a new macOS-focused cyber campaign that uses fake recruiter approaches, malicious meeting links and compromised software pipelines to steal digital assets and spread malware through trusted internal systems. The activity is being tracked as JINX-0164, a previously unreported financially motivated threat actor active since at least mid-2025. Investigators found that the group has targeted cryptocurrency organisations by approaching developers and […]
Hackers are using GHOSTYNETWORKS and OMEGATECH to sustain a global JavaScript malware operation that has targeted organisations across energy, finance, retail, automotive and government-linked sectors, underlining the expanding role of bulletproof hosting in large-scale email fraud. The campaign, tracked across March 2026 activity, used malicious ZIP and RAR attachments to deliver an obfuscated JavaScript backdoor through malspam waves sent to victims in multiple regions. Targets included energy […]
Motorola has disabled a phone software behaviour that routed some Amazon Shopping app launches through web tracking links before opening the app, after users and technology researchers found affiliate referral codes being inserted into shopping sessions without clear notice. The issue centred on Motorola’s preinstalled Smart Feed and Moto App Launcher experience, which appeared to intercept launches of Amazon from the app drawer on certain devices. Instead […]
Cybercriminals behind the ClearFake campaign have shifted deeper into blockchain-based command infrastructure, using BNB Smart Chain testnet contracts to deliver malicious code and frustrate conventional takedown efforts. The campaign marks an escalation in the abuse of decentralised infrastructure for malware operations. Instead of relying on domains, hosting providers or disposable servers that can be suspended, the operators are storing payload logic and routing instructions inside smart contracts […]
Italy has placed Rome, Florence, Bologna and Turin under its highest heat warning as an early-season heatwave pushes temperatures well above normal and raises health risks for residents, workers and visitors. The Ministry of Health’s Level 3 red alert applies on Thursday, signalling conditions that can affect not only vulnerable people but also healthy and active adults. The alert marks the first peak of the 2026 heat […]
Phuket’s private-island hospitality market has gained a sharper luxury edge as The Naka Island, a Luxury Collection Resort & Spa, Phuket, rolls out upgraded villas, refreshed dining venues, expanded wellness facilities and a Michelin One Key distinction that places the property among Thailand’s recognised high-end stays.
The resort, located on Naka Yai Island off Phuket’s east coast, has completed a series of enhancements designed to strengthen its appeal to affluent leisure travellers seeking privacy, wellness and destination-led experiences. The upgrades cover its Beachside Infinity Pool, villa interiors, spa facilities, restaurants, bar concepts and event spaces, reflecting a broader shift in Phuket’s luxury sector towards secluded, experience-rich stays rather than conventional beach resort offerings.
A central feature of the refresh is the transformed Beachside Infinity Pool, positioned against the Andaman Sea and redesigned as one of the resort’s main visual anchors. Its shape draws on Naka Yai Island and the resort’s own brand identity, while a new deck and cabana area add a stronger leisure component for guests using the beach and pool zones. The redesign gives the property a more defined social space without diluting its private-island positioning.
The villa upgrades are aimed at travellers prioritising seclusion and personal space. The resort has enhanced its private pool villas with updated interiors, bespoke furnishings and fully air-conditioned spa-style bathrooms. The emphasis on private pools in every villa aligns with demand from couples, families and long-haul guests who increasingly favour self-contained accommodation after the pandemic-era shift towards privacy-led luxury travel.
Spa Naka by HARNN has also been expanded from six to eight treatment rooms, adding capacity at a time when wellness remains one of the strongest growth areas in resort hospitality. The spa refresh includes replenished tropical gardens, upgraded pathways and new relaxation areas, reinforcing the property’s pitch as a wellness retreat rather than only a beach escape.
Dining has received equal attention. Aiyara, the resort’s signature restaurant, has been repositioned around Thai cuisine with design cues inspired by the elephant and the country’s cultural heritage. Veranda, the all-day dining venue, focuses on international menus in a beachfront setting, using natural materials such as reclaimed driftwood, rattan and pottery to reflect the surrounding marine environment. Rum Chapel offers Mediterranean flavours, seafood and imported premium ingredients, while Z Bar continues to serve as the sunset venue overlooking the Andaman.
The improvements come as Phuket’s luxury and upscale hotel market remains highly competitive, with resort operators seeking to differentiate through design, privacy, food and wellness. The island continues to attract travellers from Europe, the Middle East, Asia-Pacific and domestic markets, although Thailand’s broader tourism recovery has been uneven. Foreign arrivals rebounded strongly after border restrictions were lifted, but market composition has shifted, with softer Chinese demand and stronger competition from other regional destinations influencing pricing and occupancy.
Thailand welcomed nearly 33 million international visitors in 2025, below the previous year’s level but still among the strongest performances in Southeast Asia. Phuket remained one of the country’s most resilient destinations, supported by direct air links, villa-led accommodation, marine tourism and a mature luxury hospitality base. Upscale properties have benefited from travellers willing to spend more on privacy, wellness, curated activities and recognised hospitality standards.
The Michelin One Key recognition gives The Naka Island an additional credential in a crowded market. The Michelin hotel key system evaluates stays on criteria including architecture, character, service, comfort and value relative to the experience offered. Thailand’s 2025 selection included 62 key hotels, with The Naka Island listed among One Key properties, a category described as a very special stay. The distinction is expected to support international visibility, particularly among travellers who use independent hotel rankings to choose high-value resort stays.
The resort’s owner and operator ecosystem also adds weight to its positioning. The property is part of Marriott’s Luxury Collection portfolio, while The Erawan Group is associated with the asset as a hotel investor and operator in Thailand’s hospitality sector. The combination gives the resort access to global distribution, loyalty demand and professional asset management, while still allowing it to market itself around local identity and island seclusion.
Access remains central to the resort’s appeal. The property is reached by a short speedboat transfer from Phuket, creating a sense of separation while keeping it close to the island’s airport and main tourism infrastructure. Its location on Naka Yai allows the resort to market mangrove discovery, coastal activities, beach experiences and private dining as part of a contained luxury journey.
Cybersecurity researchers have warned that BTMOB, an Android remote access trojan, has developed into a potent tool for criminals seeking to hijack smartphones, steal data and run fraud from compromised devices. The malware, first identified in early 2025, has moved beyond the narrower behaviour associated with many banking trojans. It can capture screens, record activity, manage files, intercept credentials, control device functions and give an attacker near-live […]
Another significant step towards the success of ICVAX®
HONG KONG SAR – Media OutReach Newswire – 27 May 2026 – Immuno Cure Group (“Immuno Cure“), headquartered at Hong Kong Science Park, is pleased to announce the inauguration of the research facility for its HIV therapeutic DNA vaccine (“ICVAX®“) at the Center of International Innovation for Technology and Science (“CIITS”) located in Hetao, Shenzhen. The facility aims for the development and application of key technologies for the clinical research and commercialization of Immuno Cure’s ICVAX®. ICVAX® is developed by Immuno Cure with the aim of achieving antiretroviral therapy (“ART“)-free functional cure for HIV infection. This project is carried out in collaboration with Prof. Zhiwei CHEN, the Founding Director of the AIDS Institute of Li Ka Shing Faculty of Medicine, the University of Hong Kong (“HKU AIDS Institute“), and Prof. Hongzhou LU, President of the Third People’s Hospital of Shenzhen, in the capacity as advisors.
From left to right: Dr.Tengfei CAO, Deputy Director of CIITS; Mr. Tom LAU, Corporate Finance Director and Co-Founder of Immuno Cure; Dr. Renchen LIU, Executive Deputy Dean of Research Institute of Tsinghua University in Shenzhen and Director of CIITS; Dr. Xia JIN, CEO and Co-Founder of Immuno Cure; Prof. Zhiwei CHEN, Principal Scientific Advisor and Co-founder of Immuno Cure; Dr. Percy CHENG, Chairman and Co-Founder of Immuno Cure
CIITS is a national-level achievement transformation platform co-built by Guangdong Province, Shenzhen Municipality, and Tsinghua University, and is located at the Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone (“Hetao Co-operation Zone“). It is committed to building a world’s leading major technological innovation and industrialization platform with a global perspective. It focuses on key tracks including biomedicine, high-performance materials, and artificial intelligence (AI). It aims to aggregate global innovation resources, connect with leading enterprises, and conduct organized scientific research and achievement transformation to address national major strategic needs.
Since AIDS was first identified in 1981, 40.8 million people have died from HIV infection, with over 44.1 million people living with HIV globally. While antiretroviral therapy can effectively control HIV replication, it cannot cure the disease, highlighting the critical need for immunotherapies. Designed to enhance the host’s immune response, immunotherapies aim to achieve sustained viral control without lifelong ART, ultimately leading to complete viral suppression and functional cure. Immuno Cure’s proprietary innovative HIV therapeutic DNA vaccine, ICVAX®, induces broad-spectrum, polyfunctional virus-specific T cells to achieve the ultimate goal of ART-free functional cure of HIV infection.
Immuno Cure completed the first-in-human Phase I clinical trial of ICVAX® in November 2024, demonstrating excellent safety and promising immunogenicity. Two multi-center Phase II clinical trials—randomized, double-blind, and placebo-controlled—are scheduled to launch in Q2-2026 to evaluate the vaccine’s mechanism of action and efficacy. The trials will be conducted at Prince of Wales Hospital in Hong Kong, as well as eight top-tier hospitals in China, including the Shenzhen Third People’s Hospital, Beijing Ditan Hospital Affiliated to Capital Medical University, Beijing Youan Hospital affiliated to Capital Medical University, the Eighth People’s Hospital of Guangzhou, the Second People’s Hospital of Tianjin, the Sixth People’s Hospital of Zhengzhou, Chengdu Public Health Clinical Medical Center, and Chongqing Public Health Medical Center.
Notably, standardized testing systems for evaluating immunological and virological indicators are crucial for HIV vaccine clinical trials. However, the lack of domestic standard operating procedures (SOPs) for infectious samples in clinical trials hinders the clinical development and regulatory approval of novel infectious disease therapies like ICVAX®. The mission of this research facility at CIITS is to establish an internationally aligned standardized clinical testing system for T-cell immunogenicity and viral reservoirs, as well as identify core biomarkers associated with vaccine efficacy — filling a domestic technical gap. Immuno Cure will offer the ICVAX® Phase II clinical trial to facilitate the development of this standardized precision testing method for clinical sample analysis.
Dr. Xia JIN, CEO of Immuno Cure, stated, “I am delighted to be appointed to lead this key project of CIITS. I would also like to thank CIITS for the fully fitted modern laboratory space and the RMB10.0m funding support for this 2-year initial phase. My whole scientific team is committed to contributing diligently to the success of this project. I have no doubt that the development of a standardised testing regime would not only enhance the quality of our clinical trials for ICVAX® but would also eventually be adopted as industry and national standards for the clinical translation of medicine for HIV/AIDS and other infectious diseases.
Renchen LIU, Executive Deputy Dean of Research Institute of Tsinghua University in Shenzhen and Director of CIITS, stated, “Warmest congratulations on the inauguration of the research facility for ICVAX® at the CIITS. In the future, CIITS will continue to leverage its platform resources to implement full-chain incubation services. Project managers will provide service support throughout the entire project period, ensuring the smooth progress of the project through resource integration, talent recruitment and development, clinical collaboration, and achievement transformation. These efforts will safeguard the steady progress of the project.”
As the project advances, Immuno Cure’s ICVAX® is positioned to become the world’s first therapeutic DNA vaccine to deliver an ART-free functional cure for HIV infection, bringing new hope to people currently living with HIV. In parallel, the standardized testing platform and collaborative innovation model developed through this effort will provide a scalable, replicable blueprint for R&D of novel therapies targeting other major infectious diseases. Together, these outcomes will strengthen the global competitiveness of biomedicine development in GBA and contribute to the development of national biosecurity capabilities and a more resilient public health system.
The issuer is solely responsible for the content of this announcement.
About the Center of International Innovation for Technology and Science (“CIITS”)
Center of International Innovation for Technology and Science (CIITS), as the international headquarter of the Greater Bay Area National Center of Technology Innovation (GBA NCTI), is operated by Research Institute of Tsinghua University in Shenzhen (RITS). CIITS actively promotes the commercialization of technology and scientific advances with overseas and domestic innovation institutions and teams, as well as industry partners, focusing on areas such as biomedicine, advanced materials and artificial intelligence.
To learn more about CIITS, please follow the WeChat official account: gh_425f503135d5
About Immuno Cure
Immuno Cure is a clinical-stage biotechnology group headquartered at Hong Kong Science Park. Immuno Cure is committed to the R&D of innovative DNA vaccines and antibody immunotherapies for infectious diseases, inflammations, and cancers. Immuno Cure possesses two technologies: the “PD-1 Enhanced DNA Vaccine Platform” and the “Anti-Δ42PD1 Antibody”.